Extracts from the joint press conference by Máire Geoghegan-Quinn, Tonio Borg, and Marc Sprenger, Director of the European Centre for Disease Prevention and Control (ECDC), on the occasion of European Antibiotic Awareness Day

Type: Summary of press conference   Reference: I-083645   Duration: 10:04:51  Lieu:
End production: 15/11/2013   First transmission: 15/11/2013
On 15 November 2013, Tonio Borg, Member of the EC in charge of Health, Máire Geoghegan-Quinn, Member of the EC in charge of Research, Innovation and Science, and Marc Sprenger, Director of the European Centre for Disease Prevention and Control (ECDC), gave a joint press conference at the European Commission in Brussels, Belgium, on the occasion of the 6th European Antibiotic Awareness Day.

Only the original language version is authentic and it prevails in the event of its differing from the translated versions.
PDF version

TIME DESCRIPTION DURATION
10:00:00 Title 00:00:05
10:00:05 Exterior view of the Berlaymont building in Brussels, Belgium 00:00:05
10:00:10 Arrival of Máire Geoghegan-Quinn, Member of the EC in charge of Research, Innovation and Science, Tonio Borg, Member of the EC in charge of Health, and Marc Sprenger, Director of the European Centre for Disease Prevention and Control (ECDC), to the press conference 00:00:07
10:00:18 Soundbite by Tonio Borg, (in ENGLISH): The last time we conducted an EU wide survey on this topic was around 4 years ago and I am pleased to say that there has been and I will choose my adjectives carefully, a modest but positive evolution since then. For example, 35% of respondents say they have taken antibiotics in the past year which is a 5% decrease since the 2009 survey; 2% fewer for the flue antibiotic. 00:00:36
10:00:54 Cutaway of the speakers 00:00:03
10:00:58 Soundbite by Tonio Borg, (in ENGLISH): The Commission therefore is committed to pursuing its holistic 5 year action plan which takes a one-health approach; so it involves many sectors: human medicine, veterinary medicine, seeking to intensify the development of new antibiotics, research, animal husbandry, agricultural trade and communication which is another problem. 00:00:27
10:01:26 Cutaway of the audience 00:00:03
10:01:30 Soundbite by Tonio Borg, (in ENGLISH): Early next year, we shall adopt hopefully recommendations on reducing the overall use of anti antimicrobials in veterinary medicine. And in human medicine, we shall continue supporting the prudent use of antibiotics particularly for children and awareness rising amongst the health care professionals who need to be onboard if we need to succeed in our campaign so this applies to pharmacies, doctors and patients. 00:00:29
10:01:59 General view of the speakers 00:00:03
10:02:02 Soundbite by Máire Geoghegan-Quinn, (in ENGLISH): The EU has prioritised research to combat antimicrobial resistance since 1999 through the EU's framework programmes for research. Nearly 800 million Euros has been awarded to antimicrobial resistance projects since 1999. And I'm pleased to inform you today that we have made real progress in theses projects thanks in great part to a commitment from industry to work with us. 00:00:30
10:02:32 Cutaway of the audience 00:00:03
10:02:36 Soundbite by Máire Geoghegan-Quinn, (in ENGLISH): The reality is that the development costs of new antimicrobials are now often greater than their potential return. This is therefore crucial that public and private partners collaborate to find solutions for this serious health tread. We are doing just that with the Innovative Medicine Initiatives or IMI working with the European Federation of Pharmaceutical Industries and Associations (EFPIA). 00:00:28
10:03:04 Cutaway of a cameraman 00:00:03
10:03:08 Soundbite by Máire Geoghegan-Quinn, (in ENGLISH): We fully recognise the need to move to a global agenda and we are committed to make sure that the EU plays a leading role in collaboration with other countries and organisations such as the World Health Organization (WHO) to achieve these goals. We are here today because we are facing a serious challenge to society to ensure that future generations will have effective antibiotics to combat infection. We won't get this done without serious investments in research and innovation. 00:00:30
10:03:39 General view of the speakers 00:00:03
10:03:42 Soundbite by Marc Sprenger (in ENGLISH): We see that the rates of the Carbapenem resistant Klebsiella pneumoniae Bloodstream Infections have markedly increased to about 5% in 5 countries, mostly situated in the South of Europe. So, you may know as also mentioned by the Commissioner that the Carbapenems are indeed the last line class of antibiotics so the situation is really worrying. 00:00:32
10:04:15 Cutaway of the audience 00:00:03
10:04:18 Soundbite by Marc Sprenger (in ENGLISH): Antibiotics are frequently used inappropriately or unnecessarily in both human and animals. I'm very pleased with the results of the Eurobarometer but still, this is why the European Antibiotic Awareness Day not only here in Brussels but everywhere in Europe is so important and during this week there will be activities promoting prudent use of antibiotics in more than 40 countries around and across Europe including all EU Member States. 00:00:32
10:04:51 Speakers leaving the press room 00:00:06
Audiovisual Services
European Commission
ec.europa.eu/avservices
 
Conditions of use
© European Union, 2015